Steroid Hormone Receptors in Astrocytic Neoplasms-Reference-Cited by-同舟云学术

Steroid Hormone Receptors in Astrocytic Neoplasms

Published:1995-09-01 Issue:3 Volume:37 Page:496-504
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:

Author:

Carroll Rona S.¹,Zhang Jianping¹,Dashner Kathleen¹,Sar Madhabananda¹,Black Peter McL.¹

Affiliation:

1. Neurosurgical Laboratories and Brain Tumor Center, Brigham and Women's Hospital (RSC, JZ, KD, MS, PMcLB), The Children's Hospital (RSC, JZ, KD, MS, PMcLB), and Dana Farber Cancer Institute (PMcLB), Department of Surgery, Harvard Medical School, Boston, Massachusetts, and Department of Cell Biology and Anatomy and Laboratories for Reproductive Biology, University of North Carolina School of Medici

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Clinical Neurology,Surgery

Link

http://academic.oup.com/neurosurgery/article-pdf/37/3/496/24607328/0006123-199509000-00019.pdf

Reference54 articles.

1. Gene regulation by steroid hormones;Beato;Cell,1989

2. Hormone dependency and hormone responsiveness of endometrial adenocarcinoma to estrogens, progestins and antiestrogens;Bonte;Role of Medroxyprogesterone in Endocrine-related Tumors,1983

3. Steroid receptors in intracranial tumors;Brentani;Clin Neuropharmacol,1984

4. The treatment of ovarian cancer with medroxyprogesterone acetate;Bumma,1983

5. Surgical Pathology of the Nervous System and Its Coverings;Burger,1991

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the potentials of S4, a selective androgen receptor modulator, in glioblastoma multiforme therapy;Toxicology and Applied Pharmacology;2024-09

2. Gender differences in gliomas: From epidemiological trends to changes at the hormonal and molecular levels;Cancer Letters;2024-08

3. Exploring the Potentials of S4, A Selective Androgen Receptor Modulator, in Glioblastoma Multiforme Therapy;2024-01-18

4. Targeting androgen receptor in glioblastoma;Critical Reviews in Oncology/Hematology;2023-11

5. Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma;Molecular Cancer Therapeutics;2023-07-25